Lexeo Therapeutics, Inc. Common Stock

NASDAQ:LXEO

Biotechnology

Healthcare
$2.95 -0.94%

-$0.05 today

Market cap
$244.23M
Beta
1.39
P/E (TTM)
-4.6
EPS (TTM)
-$1.08
52W Low $3.60High $10.99

Volume 1.76M

Average 0.86M

Price history

Lexeo Therapeutics, Inc. Common Stock SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-67.55%

Period high

$10.63

Period low

$2.63

Latest

$2.95

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13G/ANov 13, 2026Nov 13, 2026
SC 13GNov 10, 2026Nov 10, 2026
EFFECTNov 4, 2026Nov 5, 2026
S-3Oct 29, 2026Oct 29, 2026
SC 13GOct 13, 2026Oct 13, 2026
8-KSep 29, 2026Sep 29, 2026
4Sep 28, 2026Sep 28, 2026
4Sep 28, 2026Sep 28, 2026
4Sep 28, 2026Sep 28, 2026
4Sep 28, 2026Sep 28, 2026
8-KSep 22, 2026Sep 22, 2026
4Aug 19, 2026Aug 19, 2026
4Aug 19, 2026Aug 19, 2026
4Aug 19, 2026Aug 19, 2026
144Aug 18, 2026Aug 18, 2026

Competitors

Who does Lexeo Therapeutics, Inc. Common Stock compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about LXEO's filings, answered from its disclosures.

What is the latest LXEO filing?

The latest filing shown is SC 13G/A dated Nov 13, 2026.

How many recent filings does LXEO have?

Intrinsic Alpha currently shows 20 recent filings for LXEO.